Bindex for Osteoporosis Diagnostics

Completed

Conditions studied: Osteoporosis, Postmenopausal

In brief

Osteoporosis is a disease that leads to impaired skeletal strength and increased fracture risk. Among 200 million osteoporotic patients most are diagnosed only after several fractures. Furthermore, the progressively aging population will increase the prevalence of osteoporosis. It is estimated that over 75% of osteoporotic patients are not diagnosed and does not receive treatment for their condition. Bindex ultrasound device has been developed and validated in Caucasian female population. In this study, diagnostic thresholds for density index as determined with Bindex will be evaluated in two different ethnic populations.

Key facts

Study ID

NCT03878732

Run by

Bone Index Finland Ltd

People needed

293

Starts

2019-03-11

Expected to finish

2020-02-07

Last updated by the study team

2020-05-01

Who can join

Age: 50 and older, up to 100. Sex: female. Healthy volunteers: accepted.

You may not qualify if…

• for non-osteoporotic groups (Hispanic or Caucasian)
• Previous osteoporosis diagnosis
• Previous or current use of anti-fracture medication

Where it is running

• New Mexico Clincial Research & Osteoporosis Center, Inc. — Albuquerque, New Mexico, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.